This case-control study evaluated the nsk of epithelial ovanan cancer associated with genital exposure to vanous forms of powder application. Cases included all women aged 20-79 years in three counties of western Washington who were diagnosed wrth borderline or invasive ovarian cancer from 1986 through 1988; 64.3% of eligible cases were interviewed. A sample of similarly aged women who lived in these counties, identified by random digit dialing, served as controls. The overall response among control women was 68.0%. Information on powder application and other potential nsk factors was ascertained during the in-person interview. Overall, ovarian cancer cases (n = 313) were more likely than controls (n = 422) to ever have used powder (age-adjusted relative nsk (RR) = 1.5, 95% confidence interval (Cl) 1.1-2.0). After adjustment for age and other methods of genital powder application (none vs. any), an elevated relative nsk of ovanan cancer was noted only for women with a history of penneal dusting (RR = 1.6, 95% Cl 1.1-2.3) or use of genital deodorant spray (RR = 1.9, 95% Cl 1.1-3.1) These results offer support for the hypothesis, raised by pnor epidemiologic studies, that powder exposure from perineal dusting contnbutes to the development of ovarian cancer, and they suggest that use of genital deodorant sprays may do so as well. Limitations of the present study include the fairly low proportion of eligible women who participated and the potential differential recall of powder usage. Am J Epidemiol 1997;145-459-65. ovarian neoplasms; powders; talc Studies documenting the migration of carbon particles and radioactive paniculate agents from the vagina to the ovaries (1, 2), as well as those that have identified talc-like particles more frequently in ovarian tumors than in normal human ovarian tissue (3), have raised concern that genital powder exposure may increase a woman's risk of developing ovarian cancer. While the results of several epidemiologic studies have suggested elevated risks for ovarian cancer among women with genital powder exposures (4-11), results have been inconsistent for particular methods of powder application (12). In this population-based case-control study, information on the method, duration, and frequency of powder application was collected to evaluate the impact of genital powder exposures on the risk of epithelial ovarian cancer.
Studies documenting the migration of carbon particles and radioactive paniculate agents from the vagina to the ovaries (1, 2), as well as those that have identified talc-like particles more frequently in ovarian tumors than in normal human ovarian tissue (3), have raised concern that genital powder exposure may increase a woman's risk of developing ovarian cancer. While the results of several epidemiologic studies have suggested elevated risks for ovarian cancer among women with genital powder exposures (4) (5) (6) (7) (8) (9) (10) (11) , results have been inconsistent for particular methods of powder application (12) . In this population-based case-control study, information on the method, duration, and frequency of powder application was collected to evaluate the impact of genital powder exposures on the risk of epithelial ovarian cancer.
MATERIALS AND METHODS
Women with invasive or borderline epithelial ovarian cancer were identified from records of the popu-lation-based Cancer Surveillance System of western Washington. Eligible case subjects included white women diagnosed between January 1, 1986, and December 31, 1988, who resided in three counties of western Washington (King, Pierce, and Snohomish counties) and were 20-79 years of age at diagnosis. After obtaining permission from their personal physicians to contact the women and obtaining written, informed consent, we successfully interviewed 329 (64.3 percent) of the 512 eligible case subjects. The remaining 183 women were not interviewed because of death prior to study contact (n -104, 20.3 percent), physician or subject refusal (n = 73, 14.3 percent), and lack of success in locating the women {n -6, 1.2 percent). Seven women whose self-reported race/ ethnicity was other than white and nine women with unknown genital powder use were also excluded. Thus, a total of 313 white women diagnosed with borderline (n = 79) or invasive (n = 234) epithelial ovarian tumors were available for analysis.
Women identified as control subjects for this study were part of a larger control pool selected by random digit dialing (13) for several studies of cancer in women. Of the total 10,109 calls made by random digit dialing, 5,853 (57.9 percent) were to nonresidential phone numbers, 3,830 (37.9 percent) were to residential phone numbers, and 426 (4.2 percent) were to numbers of unknown residential status; 3,604 (94.1 percent) of the 3,830 calls to residential households were screened for eligible women who were age matched, in 5-year age groups, to the combined female cancer case group. Of the 721 women identified who were eligible, 521 (72.3 percent) were successfully interviewed after written, informed consent was obtained. The overall response (random digit dialing screening response multiplied by the interview response) was 68.0 percent. Women who reported race/ ethnicity other than white (n -28), age greater than 79 (n -5), a history of bilateral oophorectomy (n = 58), uncertainty concerning a history of bilateral oophorectomy (n = 4), and unknown genital powder use (n = 4) were excluded, resulting in a total of 422 white control women for analysis.
Information regarding genital powder exposures was collected by structured, in-person interviews. Women were queried about storing diaphragms in powder, dusting perineal areas with powder after bathing, powdering sanitary napkins, and using genital deodorant sprays (which may contain aerosolized powder). Those who answered affirmatively were questioned further about the duration and frequency of powder application and about the types of powder applied. Powders were grouped into five categories: cornstarch, talcum powder, baby powder, deodorant powder, and scented body/bath powder. Information on demographic characteristics, reproductive history, medical and screening histories, smoking history, anthropometry, and birth control methods was also provided by the women. A calendar was used to record major life events and enhance recall of past exposures. Relevant study information was recorded only for exposures that occurred prior to the diagnosis date of cancer among the cases or the analogous reference date among controls.
Logistic regression (EGRET version 26.6; Statistics and Epidemiology Research Corporation, Seattle, Washington) was used to determine odds ratios as estimates of the relative risk for ovarian cancer associated with genital powder application and 95 percent confidence intervals (14) . For all the relative risk estimates reported in the present analysis, women who reported any method, type, or frequency of genital powder application were compared with women who stated that they had never applied genital powder in any manner (154 ovarian cancer cases and 256 controls). Trends were evaluated using the likelihood ratio statistic (14) .
First, the relative risk for ovarian cancer among women who reported exclusive use of one of the four methods of powder application was assessed (table 2) . Then, because many women used more than one method of powder application, the risk for ovarian cancer among women who reported any use of the four methods of powder application was assessed while adjusting for the other methods of powder application ( 2 ), oral contraceptive use, or parity did not alter the estimated relative risks. Information on lactation was not available. Separate analyses for women diagnosed with invasive ovarian cancer and for those diagnosed with borderline ovarian cancer produced results very similar to those presented in tables 2-5.
RESULTS
Selected characteristics of ovarian cancer cases and controls are presented in table 1. Less education, a lower household income, and a higher body mass index were more common among women with ovarian cancer than among control women, but oral contraceptive use and having had a full-term birth were less common.
Genital powder application was more common among cases (50.8 percent) than controls (39.3 percent) (table 2). There was an overall 50 percent elevation in the risk for ovarian cancer associated with the use of one or more of the four possible methods of genital powder application (95 percent CI 1.1-2.0). Among women who exclusively used a single method of powder application, ovarian cancer risk was most strongly elevated among those who dusted perineal areas with powder after bathing (RR = 1.8, 95 percent CI 1.2-2.9).
We further examined ovarian cancer risk among women who reported application of genital powders using each of the four methods, although not necessarily exclusive use of any method (table 3) No specific type of powder used for perineal dusting, diaphragm storage, or on sanitary napkins was strongly related to ovarian cancer risk, although there was a suggestion of an elevated risk associated with any use of talcum powder and bath/body powders (RR = 1.6, 95 percent Cl 0.9-2.8, and RR = 1.5, 95 percent Cl 0.9-2.4, respectively) (table 4). When specific histologic categories of ovarian tumors were examined, any genital powder application was associated with an elevated risk for serous tumors (RR = 1. 
DISCUSSION
There are several issues that should be considered in the interpretation of our results. A sizable number of women eligible for our study did not participate, particularly among those with ovarian cancer. Many women with cancer died before they could be approached about participation in this study, and others were too ill to participate. If substantial differences in powder use existed between participating and nonparticipating women, our study results may over-or underestimate the true risks for ovarian cancer. It is also possible that the completeness of the reporting of powder use differed between cases and controls, biasing our relative risk estimates to some degree.
Additionally, it is not clear how well ascertainment of perineal powder application correctly estimates actual exposure to particles in powder that may influence ovarian cancer risk. Different consumer brands of powder that women used, or even different lots of the same brand, may have varied substantially in the content of talc, asbestiform minerals, or structurally similar compounds. Powder content has also varied over time, presumably with fewer asbestiform minerals present in more recently manufactured products (17) (18) (19) .
Our results suggest that a history of perineal dusting or use of genital deodorant sprays has a modest influence on the development of epithelial ovarian tumors, whereas storing a diaphragm in powder or powdering sanitary napkins does not. Direct comparisons of our results with those of the other nine published studies (and among these studies) are somewhat limited because of differences in the definitions, groupings, and analysis of genital powder use. Nonetheless, there is some consistency in results among studies. Seven studies including the present one (4, 6, 8-11) reported elevated relative risks for ovarian cancer, ranging from 1.3 to 3.9, among women with powder exposure by "dusting of the perineum." Of the three remaining studies that evaluated the more general exposure of "talc use in genital/perineal area" (which may or may not include perineal, sanitary napkin, diaphragm, or undergarment applications), two observed a modest elevation in ovarian cancer risk (5, 7), whereas one did not (20) .
Most studies including the present one have found little, if any, excess risk for ovarian cancer among women who stored their diaphragms in powder (4-8, 10); only one study has reported a suggestion of an elevation in risk (11) . In the present study, control women more frequently reported washing their diaphragms prior to use than did ovarian cancer cases, but ovarian cancer risk was not substantially elevated for the small number of women who did not wash their diaphragms prior to use. The relation between powdering sanitary napkins and ovarian cancer risk is less clear; three studies including the present study found • Numbers do not add up to total cases and controls because women may have used a vanety of methods for powder application.
t RR, relative nsk, adjusted for age and for the other methods of genital powder application (none, any), Cl, confidence Interval.
* p value for trend < 0.05.
no association (6, 10), whereas three other studies reported moderate elevations in risk (4, 8, 11) .
Only two other studies have evaluated particular types of powder; one reported an excess risk of borderline ovarian tumors among women who used deodorant powders (8) , and another study reported an excess risk of ovarian cancer among women who used baby powders (10) . A strong relation between the types of powder used and ovarian cancer risk was not found in the present study, although there was a suggestion of an elevated risk with any use of talcum powder and bath/body powders among women using these powders for perinea] dusting, diaphragm storage, or on sanitary napkins.
The present study is the first to evaluate the association between genital deodorant spray use and ovarian cancer risk; these preliminary results require confirmation in other studies. It is difficult to postulate that an increased risk for ovarian cancer may specifically be due to powder and associated -constituents when some of the deodorant sprays do not contain aerosolized powder. It is possible that it is not powder per se A partner's use of condoms that were packed in talc could also have contributed to a woman's genital powder exposure (21) . There was insufficient information in the present study to address the influence of condom use on the risk for ovarian cancer. Seven (2.2 percent) ovarian cancer cases and 19 (4.5 percent) control women reported a history of exposure to condoms packed in talc, whereas 20 (6.4 percent) cases and 34 (8.1 percent) controls did not know if their partners had used condoms packed in talc. Furthermore, few women knew or remembered the brand of condoms their partners had used.
The specific constituent(s) of powders that may influence the development of ovarian cancer is unknown, although attention has been focused on fibrous talc particles and asbestos (17) (18) (19) 22) . Talc, a hydrous magnesium silicate, is a constituent of almost all body and baby powders except for those that are specifically labeled as talc free or pure comstarch. The nonfibrous, sheet-like layers of talc in these powders slide across each other, allowing a smooth application on the skin. Talc-based powders may also contain fibrous particles, most of which are talc fibers, but some can be asbestiform fibers (17, 18) . While pure talc is relatively nontoxic, adverse health effects can include induction of talc granulomas when introduced in open wounds and, in the occupational setting, pneumoconi-osis (talcosis) in individuals with long-term exposure to talc dust (19) . Occupational exposure to talc does not appear to increase the risk for pulmonary malignancies (19) . Most animal studies confirm this, with lung tumors developing only in rats exposed to doses of talc dust high enough to cause chronic obstructive and restrictive lung toxicity (19) . Excess ovarian tumors have not been reported in rats and mice with long-term exposure to aerosol talc (23) . In contrast, occupational exposure to asbestos fibers has been shown to cause lung tumors (24) and has been associated with the development of ovarian tumors (25) . Thus, while there is little biologic or experimental evidence to support a role for talc per se in the development of ovarian malignancies, the potential biologic effects of consumer powders (with their variable constituents) on the human ovary have not been well studied.
The prevalence of genital powder exposure reported among control women in this and other studies conducted in the United States ranges from 28 percent to 51 percent (4-6, 8, 10) . Given such a common practice, even the modest elevation in ovarian cancer risk associated with genital powder application suggested by most of the epidemiologic studies could have a notable impact on the incidence of ovarian cancer in the United States. We recommend that cohort studies address this question; these studies could eliminate concerns regarding the potential differences in the reporting of genital powder exposures between cases and controls. We also believe that further characterization of the constituents of powder products that may influence ovarian cancer risk and the investigation of their possible biologic mechanisms of carcinogenesis are warranted.
